COVID Vaccine Postmarket Monitoring Will Depend On Which Adverse Events US FDA Wants To Watch

Data monitoring (Titima Ongkantong/Shutterstock.com)
Those who receive a vaccine after approval will be alerted electronically to get their second dose, as well as report adverse events. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet